Statin use vs. average non-HDL cholesterol levels in Algeria
Algeria: Statin use vs. average non-HDL cholesterol levels was 3.3 in 2018. ▬ Flat
Statin use vs. average non-HDL cholesterol levels in Algeria, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
Algeria recorded 3.3 for statin use vs. average non-hdl cholesterol levels in 2018. That is the lowest value across all 39 years on record.
The figure is down 5.7% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Algeria peaked at 3.7 in 1997 and was at its lowest, 3.3, in 1980.
Algeria ranks 95th of 191 countries on this measure, in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 3.42 | 3.3 | 3.5 | 10 |
| 1990s | 3.63 | 3.6 | 3.7 | 10 |
| 2000s | 3.59 | 3.5 | 3.7 | 10 |
| 2010s | 3.41 | 3.3 | 3.5 | 9 |
Countries ranked near Algeria
- 95 Azerbaijan 3.3 compare
- 95 Bahrain 3.3 compare
- 95 Barbados 3.3 compare
- 95 Bolivia 3.3 compare
- 95 Bosnia and Herzegovina 3.3 compare
- 95 Cambodia 3.3 compare
- 95 China 3.3 compare
- 95 Cuba 3.3 compare
- 95 Egypt 3.3 compare
- 95 Ghana 3.3 compare
- 95 Kiribati 3.3 compare
- 95 Laos 3.3 compare
- 95 Marshall Islands 3.3 compare
- 95 Netherlands 3.3 compare
- 95 Spain 3.3 compare
- 95 Sri Lanka 3.3 compare
- 95 Suriname 3.3 compare
- 95 Turkey 3.3 compare
- 95 Turkmenistan 3.3 compare
- 95 United Kingdom 3.3 compare
- 95 United States 3.3 compare
More reference data data for Algeria
- Spring temperature anomalies -0.093 °C (2026)
- Summer temperature anomalies 1.58 °C (2026)
- Temperature anomalies by month 1.65 °C (2026)
- Universal right to vote in practice 2 (2025)
- Autumn temperature anomalies 0.7559 °C (2025)
- Winter temperature anomalies 0.0968 °C (2025)
- Consumer price index 209.51 2010 = 100 (2025)
- Universal right to vote 2 (2025)
- Competitive elections 0 (2025)
- Men's universal right to vote 1 (2025)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Algeria?
- Statin use vs. average non-hdl cholesterol levels in Algeria was 3.3 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Algeria?
- The highest recorded value was 3.7 in 1997.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Algeria?
- The lowest recorded value was 3.3 in 1980.
- How does Algeria rank for statin use vs. average non-hdl cholesterol levels?
- Algeria ranks 95th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Algeria?
- Over the last ten years it is down 5.7%. The long-run trend across the full record is flat.
- Where does this Algeria data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.